Novavax Says Could Offer COVID-19 Vaccine Together With Flu Shot for Boosters

Researchers at the UW Medicine Retrovirology Research Lab at Harborview Medical Center work on samples from the Novavax phase 3 Covid-19 clinical vaccine trial in Seattle, Washington on Feb. 12, 2021. Karen Ducey/Getty Images

Novavax on Monday said that co-administering its protein-based COVID-19 vaccine with an approved flu shot may be a “viable immunization strategy” in the future, based on preliminary findings from a recent study.

The American biotech firm made the announcement on Monday based on data from the first co-administration study of a COVID-19 vaccine candidate and an approved influenza vaccine.